Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
IRCT20170411033365N2Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine in postoperative nausea and vomiting (PONV), sponsored by Urmia University of Medical Sciences. Primary endpoint: postoperative nausea and vomiting incidence. Started Jun 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20170411033365N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170411033365N2.